These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12866973)
1. [Research advances on inhibitor of apoptosis, survivin]. Yang J; Liu FX; Yan XC Ai Zheng; 2003 Jul; 22(7):771-4. PubMed ID: 12866973 [TBL] [Abstract][Full Text] [Related]
2. The role of survivin as a new target of diagnosis and treatment in human cancer. Yamamoto T; Tanigawa N Med Electron Microsc; 2001 Dec; 34(4):207-12. PubMed ID: 11956993 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Chen J; Wu W; Tahir SK; Kroeger PE; Rosenberg SH; Cowsert LM; Bennett F; Krajewski S; Krajewska M; Welsh K; Reed JC; Ng SC Neoplasia; 2000; 2(3):235-41. PubMed ID: 10935509 [TBL] [Abstract][Full Text] [Related]
5. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome. Nassar A; Lawson D; Cotsonis G; Cohen C Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733 [TBL] [Abstract][Full Text] [Related]
6. Survivin, versatile modulation of cell division and apoptosis in cancer. Altieri DC Oncogene; 2003 Nov; 22(53):8581-9. PubMed ID: 14634620 [TBL] [Abstract][Full Text] [Related]
7. Survivin and apoptosis control. Altieri DC Adv Cancer Res; 2003; 88():31-52. PubMed ID: 12665052 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648 [TBL] [Abstract][Full Text] [Related]
9. [Development of a novel gene therapy using survivin antisense expressing adenoviral vectors]. Yamamoto T; Manome Y; Miyamoto A; Tanigawa N Gan To Kagaku Ryoho; 2003 Oct; 30(11):1805-8. PubMed ID: 14619525 [TBL] [Abstract][Full Text] [Related]
10. Survivin as a target for new anticancer interventions. Zaffaroni N; Pennati M; Daidone MG J Cell Mol Med; 2005; 9(2):360-72. PubMed ID: 15963255 [TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of apoptosis protein inhibitor survivin and XIAP, in patients with myelodysplastic syndromes and in the cell line MUTZ-1]. Cai Z; Bao HY; Ludwig WD; Wuchter C Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):26-30. PubMed ID: 14990073 [TBL] [Abstract][Full Text] [Related]
12. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Mita AC; Mita MM; Nawrocki ST; Giles FJ Clin Cancer Res; 2008 Aug; 14(16):5000-5. PubMed ID: 18698017 [TBL] [Abstract][Full Text] [Related]
13. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302 [TBL] [Abstract][Full Text] [Related]
14. Survivin: a protein with dual roles in mitosis and apoptosis. Wheatley SP; McNeish IA Int Rev Cytol; 2005; 247():35-88. PubMed ID: 16344111 [TBL] [Abstract][Full Text] [Related]
15. Survivin and leukemia. Cong XL; Han ZC Int J Hematol; 2004 Oct; 80(3):232-8. PubMed ID: 15540897 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Tu SP; Cui JT; Liston P; Huajiang X; Xu R; Lin MC; Zhu YB; Zou B; Ng SS; Jiang SH; Xia HH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC Gastroenterology; 2005 Feb; 128(2):361-75. PubMed ID: 15685548 [TBL] [Abstract][Full Text] [Related]
17. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. Beltrami E; Plescia J; Wilkinson JC; Duckett CS; Altieri DC J Biol Chem; 2004 Jan; 279(3):2077-84. PubMed ID: 14581472 [TBL] [Abstract][Full Text] [Related]
18. Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death. Malcles MH; Wang HW; Koumi A; Tsai YH; Yu M; Godfrey A; Boshoff C Br J Cancer; 2007 Jun; 96(11):1659-66. PubMed ID: 17505517 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021 [TBL] [Abstract][Full Text] [Related]
20. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]